A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/2002
12/27/2002	WO2002076946A3 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain.
12/27/2002	WO2002072619A9 INTEGRIN αIIbβ3 ACTIVATING PEPTIDES AND THEIR USE
12/27/2002	WO2002070473A3 Carboxamide derivatives as therapeutic agents
12/27/2002	WO2002062335A3 Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
12/27/2002	WO2002018445A8 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
12/27/2002	CA2451874A1 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells
12/27/2002	CA2450845A1 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state
12/27/2002	CA2450809A1 Methods for detecting and treating the early onset of aging-related conditions
12/27/2002	CA2450732A1 Stabilized proteins with engineered disulfide bonds
12/27/2002	CA2450067A1 Proteins associated with cell growth, differentiation, and death
12/27/2002	CA2443466A1 An aqueous pharmaceutical preparation of cilostazol for parenteral use
12/27/2002	CA2429113A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors
12/26/2002	US20020198363 Generation of antithrombic protein; obtain nucleotide sequences coding antithrombic protein, transform microorganism, express nucleotide sequences, recover protein
12/26/2002	US20020198362 Peptide or polypeptide for use in the diagnosis, prevention and treatment of blood disorders and leukemias
12/26/2002	US20020198253 Melatonin derivatives and medicine containing same
12/26/2002	US20020198251 Substituted 2-dialkylaminoalkylbiphenyl derivatives
12/26/2002	US20020198236 Small organic molecule regulators of cell proliferation
12/26/2002	US20020198229 Polymorphic form of clopidogrel hydrogen sulphate
12/26/2002	US20020198211 cDNA for human methylenetetrahydrofolate reductase and uses thereof
12/26/2002	US20020198199 Such as 2-(2-(N-((4-aminoiminomethylphenyl)methyl)-3-(3-aminophenyl)-6-(N,N -dimethylhydrazino)-1-oxypyridinyl))acetami de which inhibit serine proteases for preventing and treating thrombotis
12/26/2002	US20020198196 Novel cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
12/26/2002	US20020198195 New oxybenzamide derivatives useful for inhibiting factor Xa or VIIa
12/26/2002	US20020198193 Novel 5-thio-B-D-xylopryanoside derivatives, preparation, method, pharmaceutical compositions containing them and their therapeutic use
12/26/2002	US20020198152 Administering to an obese patient or one at risk of becoming obese a therapeutic compound that attenuates the binding of agouti-related protein to melanocortin receptors, free of binding of alpha-melanocyte stimulating hormone to receptor
12/26/2002	US20020198143 B7-like polynucleotides, polypeptides, and antibodies
12/26/2002	US20020198142 Integrin inhibitors, for the treatment of disorders caused by implants, defects, inflammations and of osteolytic disorders such as osteoporosis, thrombosis, cardiac infarct and arteriosclerosis
12/26/2002	US20020197667 Polypeptide for use in the treatment of thrombosis and sepsis
12/26/2002	US20020197246 Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases
12/25/2002	CN1387576A Sequence-specific DNA recombination in ekaryotic cells
12/25/2002	CN1387575A Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins
12/25/2002	CN1387538A Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders
12/25/2002	CN1387528A Heterocyclic substd, pyrazolones
12/25/2002	CN1387514A Aromatic sulfone hydroxamic acid metalloprotease inhibitor
12/25/2002	CN1387508A N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
12/25/2002	CN1386752A Gene-recombinant anticoaglant protein
12/25/2002	CN1386750A Process for preparing platelet factor 4 as genetically engineered medicine
12/25/2002	CN1386543A Process for preparing medicine 'Maikang mixture'
12/25/2002	CN1097052C Process for production of amidinoindole derivs, and salts thereof
12/25/2002	CN1096834C Flavonol contg. food supplements
12/24/2002	US6498274 Amide derivatives for the treatment of diseases mediated by cytokines
12/24/2002	US6498243 Epimorphin antagonist and process for producing it
12/24/2002	US6498185 Enzyme factor xa inhibitors
12/24/2002	US6498155 Methods of treating thrombocytopenia
12/24/2002	US6498150 Low molecular weight cell, bone marrow and immune stimulants
12/24/2002	US6498141 Method and apparatus for preparing an acellular red blood cell substitute
12/24/2002	US6497869 Having a ph of 5.0 to 8.0, and a salt comprising sulfate ions; treatment of shipping fever, bovine mastitis
12/21/2002	CA2390966A1 Compound for the treatment of atherosclerotic-thrombotic pathological conditions
12/19/2002	WO2002101069A2 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
12/19/2002	WO2002101048A2 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
12/19/2002	WO2002101021A2 Purification of human serum albumin
12/19/2002	WO2002100899A2 Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein
12/19/2002	WO2002100898A2 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same
12/19/2002	WO2002100886A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa
12/19/2002	WO2002100862A2 Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine
12/19/2002	WO2002100847A2 Factor xa inhibitor
12/19/2002	WO2002100830A1 Pyrrolidine derivatives as factor xa inhibitors
12/19/2002	WO2002100456A1 Using supercritical fluids to infuse therapeutic on a medical device
12/19/2002	WO2002100416A1 Socs-5 molecules, screening therefore and therapeutic uses thereof
12/19/2002	WO2002100414A1 Arylazo-substituted imidazole for the treatment of stress urinary incontinence
12/19/2002	WO2002100405A1 Isoquinoline inhibitors of p38
12/19/2002	WO2002100400A1 Organic nitrate-based compounds for the treatment of vasculopathies
12/19/2002	WO2002100341A2 Compounds for the treatment of metabolic disorders
12/19/2002	WO2002100332A2 Isoxazoline compounds having mif antagonist activity
12/19/2002	WO2002100330A2 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES
12/19/2002	WO2002100327A2 Substituted 1-benzazepines and derivatives thereof
12/19/2002	WO2002085906A3 Phthalazinones derivatives useful as pde4/7 inhibitors
12/19/2002	WO2002070561A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070560A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070558A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002069899A3 Methods and compositions for the treatment and prevention of smooth muscle cell proliferation
12/19/2002	WO2002064755A3 Post-partum mammalian placenta, its use and placental stem cells therefrom
12/19/2002	WO2002060894A3 Sulfonamide lactam inhibitors of factor xa
12/19/2002	WO2002059128A3 Process for preparing clopidogrel
12/19/2002	WO2002042248A3 Naphthalene derivatives
12/19/2002	WO2001077169A9 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
12/19/2002	WO2001047919A9 Substituted oxazolidinones and their use in the field of blood coagulation
12/19/2002	US20020193612 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
12/19/2002	US20020193595 Agonists of the melanocortin-4 receptor ("MC-4r"); useful treating obesity and type 2 diabetes
12/19/2002	US20020193571 Wsx receptor agonist antibodies
12/19/2002	US20020193432 Useful as modulators of the interaction between the receptor for advanced glycated end product and its ligands
12/19/2002	US20020193410 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans
12/19/2002	US20020193405 For prophylaxis and therapy of diseases, such as cell proliferation or apoptosis mediated diseases
12/19/2002	US20020193398 For therapy and prophylaxis of blood coagulation and cardiovascular disorders
12/19/2002	US20020193396 Sulfonamido ether substituted imidazoquinolines
12/19/2002	US20020193375 Heterocyclic derivatives which inhibit factor Xa
12/19/2002	US20020193348 As blood-coagulation inhibitor or an agent for therapy and prophylaxis of thrombosis or embolism, containing
12/19/2002	US20020193293 Low oxygen affinity mutant hemoglobins
12/19/2002	US20020193288 Methods of treating hypertension and compositions for use therein
12/19/2002	US20020192826 Recombinant AAV vector-based transduction system and use of same
12/19/2002	US20020192794 Purification of plasmin; obtain sample of plasminogen, incubate with activator, recover plasmin
12/19/2002	US20020192749 Human polynucleotides, polypeptides, and antibodies
12/19/2002	US20020192737 Detecting modulators of oxidoreductases; obtain sample, incubate with modulator, detect signal, monitor adjustment in enzyme activity
12/19/2002	US20020192285 Controlled release pellet formulation
12/19/2002	US20020192207 Pharmaceutical compositions of fibrinolytic agent
12/19/2002	CA2449957A1 Arylazo-substituted imidazole for the treatment of stress urinary incontinence
12/19/2002	CA2449629A1 Pyrrolidine derivatives as factor xa inhibitors
12/19/2002	CA2449602A1 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
12/19/2002	CA2449259A1 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same
12/19/2002	CA2448432A1 Purification of human serum albumin
12/19/2002	CA2447687A1 Substituted 1-benzazepines and derivatives thereof

1 ... 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 ... 671